The Meningococcal Vaccine — Public Policy and Individual Choices

Publisher Website
Google Scholar
Abstract
Every year there are approximately 2200 to 3000 cases of invasive meningococcal disease in the United States. Because of its low cost effectiveness and other limitations, routine use of the meningococcal vaccine is not recommended. However, individual choices may differ from public policy considerations. If parents were aware of this option, many might choose to pay for vaccination in order to protect adolescents and young adults from this devastating infection. Parents and patients need information about the availability of all effective vaccines.

This publication has 17 references indexed in Scilit: